Skip to main content

Table 4 ORs and 95% CIs of muscle mass and muscle strength for NAFLD

From: Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang Province, China: a cross-sectional observational study

 

Men

Variable

Model 1

Model 2

OR (95%CI)

P

OR (95%CI)

P

Muscle mass, per SD decrease

2.91 (1.58, 5.35)

0.001

2.88 (1.52, 5.46)

0.001

Muscle strength, per SD decrease

1.15 (1.04, 1.26)

0.004

1.15 (1.02, 1.28)

0.021

Women

Variable

Model 1

Model 2

OR (95%CI)

P

OR (95%CI)

P

Muscle mass, per SD decrease

1.89 (1.51, 2.38)

<0.001

2.08 (1.63, 2.67)

<0.001

Muscle strength, per SD decrease

1.05 (0.99, 1.11)

0.058

1.01 (0.95, 1.07)

0.716

  1. Results are given as OR (95% CI) for NAFLD as outcome stratified by gender. Results in bold reflect significant findings with a P value < 0.05. Model 1: adjusted for age and weight. Model 2: adjusted for age, weight, BMI, TG, ALT. NAFLD, nonalcoholic fatty liver disease; BMI, body mass index; TG, triglyceride; ALT, alanine aminotransferase